Rezaeian AH, Isokane T, Nishibori M, Chiba M, Hiraiwa N, Yoshizawa M, Yasue H (Жовтень 2009). alphaCGRP and betaCGRP transcript amount in mouse tissues of various developmental stages and their tissue expression sites. Brain & Development. 31 (9): 682—93. doi:10.1016/j.braindev.2008.10.011. PMID19062206.(англ.)
Chen LJ, Zhang FG, Li J, Song HX, Zhou LB, Yao BC, Li F, Li WC (Січень 2010). Expression of calcitonin gene-related peptide in anterior and posterior horns of the spinal cord after brachial plexus injury. Journal of Clinical Neuroscience. 17 (1): 87—91. doi:10.1016/j.jocn.2009.03.042. PMID19969463.(англ.)
Arulmani U, Maassenvandenbrink A, Villalón CM, Saxena PR (Жовтень 2004). Calcitonin gene-related peptide and its role in migraine pathophysiology. European Journal of Pharmacology. 500 (1—3): 315—30. doi:10.1016/j.ejphar.2004.07.035. PMID15464043.(англ.)
Goadsby PJ, Edvinsson L (Червень 1994). Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain. 117 ( Pt 3) (3): 427—34. doi:10.1093/brain/117.3.427. PMID7518321.(англ.)
Lattanzi S, Brigo F, Trinka E, Vernieri F, Corradetti T, Dobran M, Silvestrini M (Лютий 2019). Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety. Drugs. doi:10.1007/s40265-019-01069-1. PMID30793254.(англ.)
Bigal ME, Rapoport AM, Silberstein SD, Walter S, Hargreaves RJ, Aycardi E (Листопад 2018). From LBR-101 to Fremanezumab for Migraine. CNS Drugs. 32 (11): 1025—1037. doi:10.1007/s40263-018-0579-4. PMID30311143.(англ.)
Bank, James (16 січня 2018). CGRP: What You Need To Know. National Headache Foundation. Архів оригіналу за 24 лютого 2019. Процитовано 23 лютого 2019.(англ.)
Rezaeian AH, Isokane T, Nishibori M, Chiba M, Hiraiwa N, Yoshizawa M, Yasue H (Жовтень 2009). alphaCGRP and betaCGRP transcript amount in mouse tissues of various developmental stages and their tissue expression sites. Brain & Development. 31 (9): 682—93. doi:10.1016/j.braindev.2008.10.011. PMID19062206.(англ.)
Chen LJ, Zhang FG, Li J, Song HX, Zhou LB, Yao BC, Li F, Li WC (Січень 2010). Expression of calcitonin gene-related peptide in anterior and posterior horns of the spinal cord after brachial plexus injury. Journal of Clinical Neuroscience. 17 (1): 87—91. doi:10.1016/j.jocn.2009.03.042. PMID19969463.(англ.)
Arulmani U, Maassenvandenbrink A, Villalón CM, Saxena PR (Жовтень 2004). Calcitonin gene-related peptide and its role in migraine pathophysiology. European Journal of Pharmacology. 500 (1—3): 315—30. doi:10.1016/j.ejphar.2004.07.035. PMID15464043.(англ.)
Goadsby PJ, Edvinsson L (Червень 1994). Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain. 117 ( Pt 3) (3): 427—34. doi:10.1093/brain/117.3.427. PMID7518321.(англ.)
Lattanzi S, Brigo F, Trinka E, Vernieri F, Corradetti T, Dobran M, Silvestrini M (Лютий 2019). Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety. Drugs. doi:10.1007/s40265-019-01069-1. PMID30793254.(англ.)
Bigal ME, Rapoport AM, Silberstein SD, Walter S, Hargreaves RJ, Aycardi E (Листопад 2018). From LBR-101 to Fremanezumab for Migraine. CNS Drugs. 32 (11): 1025—1037. doi:10.1007/s40263-018-0579-4. PMID30311143.(англ.)
Bank, James (16 січня 2018). CGRP: What You Need To Know. National Headache Foundation. Архів оригіналу за 24 лютого 2019. Процитовано 23 лютого 2019.(англ.)
Rezaeian AH, Isokane T, Nishibori M, Chiba M, Hiraiwa N, Yoshizawa M, Yasue H (Жовтень 2009). alphaCGRP and betaCGRP transcript amount in mouse tissues of various developmental stages and their tissue expression sites. Brain & Development. 31 (9): 682—93. doi:10.1016/j.braindev.2008.10.011. PMID19062206.(англ.)
Chen LJ, Zhang FG, Li J, Song HX, Zhou LB, Yao BC, Li F, Li WC (Січень 2010). Expression of calcitonin gene-related peptide in anterior and posterior horns of the spinal cord after brachial plexus injury. Journal of Clinical Neuroscience. 17 (1): 87—91. doi:10.1016/j.jocn.2009.03.042. PMID19969463.(англ.)
Arulmani U, Maassenvandenbrink A, Villalón CM, Saxena PR (Жовтень 2004). Calcitonin gene-related peptide and its role in migraine pathophysiology. European Journal of Pharmacology. 500 (1—3): 315—30. doi:10.1016/j.ejphar.2004.07.035. PMID15464043.(англ.)
Goadsby PJ, Edvinsson L (Червень 1994). Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain. 117 ( Pt 3) (3): 427—34. doi:10.1093/brain/117.3.427. PMID7518321.(англ.)
Lattanzi S, Brigo F, Trinka E, Vernieri F, Corradetti T, Dobran M, Silvestrini M (Лютий 2019). Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety. Drugs. doi:10.1007/s40265-019-01069-1. PMID30793254.(англ.)
Bigal ME, Rapoport AM, Silberstein SD, Walter S, Hargreaves RJ, Aycardi E (Листопад 2018). From LBR-101 to Fremanezumab for Migraine. CNS Drugs. 32 (11): 1025—1037. doi:10.1007/s40263-018-0579-4. PMID30311143.(англ.)